MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPDV
Gel-filtration was conducted using AKTAxpress (18-6645-05, GE Healthcare) with XK 16x65 columns (part numbers 18-1031-47 and 18-6488-01, GE Healthcare) packed with HighLoad Superdex 200 resin (10-1043-04, GE Healthcare). Pre-equilibration was done with gel filtration buffer at a flow rate of 3 mL/min. 7 mL of protein sample was loaded onto the column at 1.5 mL/min, and 2 mL fractions are collected in 96-well plates (VWR 40002-012) using peak fractionation protocols with the following parameters: (Slope; min. peak width 0.833 min; level 0.000 mAU; peak start slope 10.000 AU/min; peak end slope 20.000 AU/min). Fractions were analyzed for purity using SDS-PAGE and those containing pure Mer/axl2 were pooled.
Purified protein was concentrated using 15 mL concentrators with a 10,000 molecular weight cut-off (Amicon Ultra-15, UFC900524, Millipore) at 3750 rpm, typically resulting in a final concentration of 7-10 mg/mL.
Crystals were obtained at 14 oC using the hanging-drop vapour-diffusion method by mixing 2 ul Mer solution with 2 ul reservoir (100 mM Tris-HCl pH 8.5, 200 mM MgCl2, 29% PEG 400). Cryo buffer was composed of glycerol, ethylene glycol, glucose, and fructose.
NMR Spectroscopy:
Data Collection:
Data Processing: